Direct Repair On
A Beating Heart
The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. LEARN MORE ABOUT THE PROCEDURE
Direct Repair On
A Beating Heart
The NeoChord
A Beating Heart
The NeoChord Artificial Chordae Delivery System is a beating heart procedure, echo-guided treatment option for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. LEARN MORE ABOUT THE PROCEDURE
Direct Repair On
A Beating Heart
The NeoChord
Location: United States, Minnesota, Saint Louis Park
Employees: 11-50
Total raised: $97.6M
Founded date: 2012
Investors 5
| Date | Name | Website |
| - | US Venture... | usvp.com |
| - | Mayo Clini... | ventures.m... |
| - | TGap Ventu... | tgapvcfund... |
| 17.07.2021 | Baird Capi... | bairdcapit... |
| - | Treo Ventu... | treovp.com |
Funding Rounds 6
| Date | Series | Amount | Investors |
| 24.04.2019 | Series D | $32M | - |
| 05.11.2018 | Series D | $25M | - |
| 09.06.2015 | Series C | $20M | - |
| 22.05.2015 | - | $12.6M | - |
| 25.10.2013 | - | $3M | - |
| 02.08.2011 | - | $5M | - |
Mentions in press and media 18
| Date | Title | Description |
| 22.02.2024 | NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation | - |
| 08.10.2021 | Baird Capital Portfolio Company NeoChord Announces Successful In-Human Procedure | Baird Capital portfolio company NeoChord, a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, recently announced successful completi... |
| 02.05.2019 | NeoChord Raises Additional Financing to Drive Catheter‐based Program Development, Bringing Total Series D Funding to over $32 Million. | - |
| 24.04.2019 | NeoChord Raises Additional $7M in Series D Financing | NeoChord, Inc., a St. Louis Park, Minn.-based medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, secured approx. $7m in additional funding as an ext... |
| 05.11.2018 | NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs | - |
| 05.11.2018 | NeoChord Raises $25M in Series D Financing | NeoChord, Inc., a St. Louis Park, Minn.-based medical technology company, completed a $25m Series D equity financing. The round was led by U.S. Venture Partners and co-led by Deerfield Management with continued participation from Baird Capi... |
| 09.06.2015 | NeoChord Closes $20M Series C Financing Round | NeoChord, a Eden Prairie, Minnesota-based medical technology company, closed a $20m Series C financing round. The round was led by Deerfield Management, with participation from Baird Capital’s Venture Capital group, and existing investors H... |
| 09.06.2015 | NeoChord Secures $20 Million Series C Financing | Eden Prairie, Minn., June 9 2015 – NeoChord, a medical technology company, announced today it has closed an oversubscribed $20 million Series C financing round led by Deerfield Management, with participation from Baird Capital's Venture Cap... |
| 22.05.2015 | NeoChord gets $12.6M for mitral valve repair tool that works without stopping the heart | It requires a two- to three-inch incision between the ribs (many repair procedures require the sternum to be cut and the rib cage spread open) and, with ECG guidance, the device can capture and suture the mitral valve leaflets. Read more he... |
| 28.03.2014 | Surgical tray manufacturer raises $500,000 to make fancier cases faster | Founded in 2011, the company makes trays to transport and organize instruments and implants as well as clean and store the tools. The company also offers product branding including specific colors and 3D graphics. Greg Maurer, owner of the ... |
Show more